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Abstract Essential tremor (ET) presumably has a cerebellar
origin. Imaging studies showed various cerebellar and also
cortical structural changes. A number of pathology studies
indicated cerebellar Purkinje cell pathology. ET is a heteroge-
neous disorder, possibly indicating different underlying dis-
ease mechanisms. Familial cortical myoclonic tremor with
epilepsy (FCMTE), with evident Purkinje cell degeneration,
can be an ET mimic. Here, we investigate whole brain and,
more specifically, cerebellar morphological changes in hered-
itary ET, FCMTE, and healthy controls. Anatomical magnetic
resonance images were preprocessed using voxel-based mor-
phometry. Study 1 included voxel-wise comparisons of 36
familial, propranolol-sensitive ET patients, with subgroup
analysis on age at onset and head tremor, and 30 healthy
controls. Study 2 included voxel-wise comparisons in another
nine ET patients, eight FCMTE patients, and nine healthy
controls. Study 3 compared total cerebellar volume between
45 ET patients, 8 FCTME patients, and 39 controls. In our
large sample of selected hereditary ET patients and ET sub-
groups, no local atrophy was observed compared to healthy
controls or FCMTE. In ET patients with head tremor, a vol-
ume increase in cortical motor regions was observed. In
FCMTE, a decrease in total cerebellar volume and in local
cerebellar gray matter was observed compared to healthy con-
trols and ET patients. The current study did not find local
atrophy, specifically not in the cerebellum in hereditary ET,
contrary to FCMTE. Volume increase of cortical motor areas
in ET patients with head tremor might suggest cortical plas-
ticity changes due to continuous involuntary head
movements.
Keywords Essential tremor .MRI . VBM . Volumetry .
FCMTE . Cerebellum
Introduction
Essential tremor (ET) is one of the most common neurological
disorders, characterized by a progressive postural and kinetic
tremor [1, 2]. Moreover, ET is a heterogeneous disorder; pa-
tients differ in the presence of head tremor, family history, and
response to medication, possibly indicating different underly-
ing disease mechanisms [3]. It has even been suggested that
the presence of head tremor and early versus late disease onset
might differentiate between ET subtypes [4, 5].
Clinical, imaging, and pathology findings point to cerebel-
lar dysfunction in ET. ET patients can show an ataxic gait, eye
movement abnormalities, and intention tremor, and symptoms
often diminish upon alcohol consumption [6–14]. Functional
and metabolic abnormalities have been demonstrated in the
cerebellum and brainstem by functionalMRI (fMRI), magnet-
ic resonance spectroscopy, and diffusion tensor imaging
[15–18]. Several, mainly structural imaging studies, indicated
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various cortical changes including volume decrease in the
temporal lobe [19–21], frontal lobe [20, 22], parietal lobe
[19–22], and occipital lobe [19, 20] (see Sharifi et al.[23] for
a review). The jury is still out on whether atrophy is a true
hallmark of ET.
Currently, there are three mutually non-exclusive hypothe-
ses about the pathophysiology of ET [24]. Reports of allevia-
tion of tremor after thalamic deep brain stimulation and after
stroke within the physiological central motor network, or
cerebello-thalamo-cortical network, prompted the hypothesis
of essential tremor as an Boscillating network disorder^ [25].
A second hypothesis labels ET as a neurodegenerative disor-
der, with pathology studies showing evidence for structural
cerebellar changes, with Purkinje cell loss and axonal swell-
ing, and simultaneous remodeling of the cerebellar cortex
[26–31]. A third hypothesis is associating ET with abnormal
functioning of the inhibitory neurotransmitter gamma-
Aminobutyric acid (GABA).
Another neurological disorder, known to be associated
with Purkinje cell changes and cerebellar atrophy, is familial
cortical myoclonic tremor and epilepsy (FCMTE), also re-
ferred to as familial adult myoclonic epilepsy (FAME).
FCMTE is a heritable disease characterized by progressive
myoclonus of the distal limbs and infrequent epileptic seizures
and signs of cortical hyperexcitability [32–34]. Autosomal
dominant FCMTE/FAME has been linked to various chromo-
somal loci [35–38]. FCMTE has been associated with cere-
bellar atrophy and decreased cerebellar fiber density [33, 34,
39]. Clinically, the tremulous movements of FCMTE can be
confused with ET [40]. It would be of interest to see whether
structural cerebellar abnormalities in ET, if present, are com-
parable to those in FCMTE, considering that Purkinje cells are
hypothesized to be affected in both conditions.
This study has been divided in three parts. Study 1 aims to
answer the question whether atrophy is a true hallmark of
(subgroups of) ET. In order to accomplish this, we set out to
investigate volumetric differences in a large, clinically well-
defined, group of hereditary ET patients, compared with
healthy controls. In light of the large clinical heterogeneity
of ET, for study 1, we have selected ET patients with a positive
family history and a disease onset before the age of 65. Pre-
viously, this operational definition was termed Bhereditary
ET^ [4]. Furthermore, patients had to report a positive effect
for propranolol treatment. As it has been suggested that the
presence of head tremor and disease onset represent different
ET subtypes [4, 5], subgroup analyses were performed in ET
patients (1) with and without head tremor and (2) with early
versus late onset tremor (before or after the 40 years of age)
[41]. For study 1, we expect volumetric changes in the ET
group, if present at all, to be confined to the cerebellum.
Study 2 aims to compare volumetric changes in ET,
FCMTE, and healthy controls. We expect no or localized cer-
ebellar atrophy in ET and generalized cerebellar atrophy in
FCMTE. To further increase the sensitivity of our data analy-
sis, the spatially unbiased infratentorial template (SUIT [42])
is used, developed specifically for the cerebellum and present-
ly the most accurate method to detect volumetric differences
in the cerebellum [42]. Finally, in study 3, global cerebellar
volume will be compared between ET and FCMTE patients,
and healthy controls.
Materials and Methods
The study was conducted in two academic hospitals in the
Netherlands: the Academic Medical Center in Amsterdam
(AMC) and the University Medical Center Groningen
(UMCG).
Study 1—ET Patients and Controls
Thirty-six propranolol-sensitive ET patients with familial up-
per limb tremor and 30 age- and gender-matched healthy con-
trols were included for study 1. All subjects were right-handed
according to the Annett handedness questionnaire and gave
written informed consent before participation. Patients were
included when they fulfilled the clinical criteria defined by the
Tremor Investigation Group [43], reported a positive effect of
propranolol on tremor, had a positive family history of at least
one affected relative in immediate family and tremor onset
before the age of 65 years, a disease duration longer than
5 years, and were aged 18 years or older. Tremor on and off
propranolol medication was recorded on video using the
Fahn-Tolosa-Marin Tremor Rating Scale (TRS) parts A and
B [44] and assessed, blinded for medication condition, by a
movement disorder specialist (JDS). Part A consists of assess-
ment of tremor amplitude during rest, posture, movement, and
finger-to-nosemanoeuvres. Part B consists of tremor-inducing
tasks, including writing, two standardized Archimedes spirals,
a line drawing task, and a water pouring task. To determine the
treatment effect of propranolol, patients quit their medication
minimally 3 days before the off-medication tremor assess-
ment. Exclusion criteria for both groups were (other) neuro-
logical disorders and cognitive dysfunction (i.e., mini-mental
state examination <26). Furthermore, ET patients using other
tremor medication such as anti-epileptic drugs were not in-
cluded. See Table 1 for full subject characteristics. The study
was approved by the medical ethical committees of both cen-
ters and conducted according to the Declaration of Helsinki
(Seoul, 2008).
Study 2—FCMTE Patients, ET Patients, and Controls
We have included nine additional ET patients, matched to
eight FCMTE patients, and nine healthy controls for study 2,
who have been scanned and described in previous reports [39,
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45]. See Table 1 for full subject characteristics. ET patients
were included when they fulfilled the clinical criteria defined
by the Tremor Investigation Group [43]; propranolol respon-
siveness and a positive family history were not required for
study 2. ET patients had a moderately severe tremor assessed
clinically, but no video recordings are available to assess the
Fahn-Tolosa-Marin Tremor Rating Scale. Myoclonus severity
for the FCMTE patients was scored using the Unified Myoc-
lonus Rating Scale (UMRS [46]).
Study 3—Total Cerebellar Volume in FCMTE Patients,
ET Patients, and Controls
To assess global cerebellar volume differences, subjects from
studies 1 and 2 were pooled.
Data Acquisition
For study 1, a high-resolution anatomical T1 3D Turbo Field
Echo (TFE) image was obtained (echo time 3.53 ms,
repetition time 9 ms, flip angle 8°, field of view 256×
256 mm, voxel size 1 mm3, number of slices 170. For study
2, high-resolution anatomical T1 3D Fast Field Echo (FFE)
images were obtained with the same spatial resolution (for
details, see van Rootselaar et al. [45]). Foam padding was used
to minimize head motion during scanning. Due to differences
in acquisition parameters, T1 images of study 1 and study 2
could not be pooled for the voxel-based morphometry (VBM)
analysis and are therefore analyzed separately. Note that for
this reason, results can also not be compared between
studies 1 and 2 directly.
DARTEL Preprocessing (Cerebral Cortex)
Preprocessing and data analysis was carried out with Statisti-
cal Parametric Mapping 8 (SPM8, Wellcome Trust Centre for
Neuroimaging, UCL, London, UK; http://www.fil.ion.ucl.ac.
uk/spm) implemented in MATLAB (Mathworks, Sherborn,
MA), using the VBM8 toolbox (http://dbm.neuro. uni-jena.
de/vbm/). T1 images were segmented in gray matter and
white matter and subsequently spatially normalized using
the diffeomorphic anatomical registration through an
exponentiated Lie algebra (DARTEL) approach [47]. The
resulting transformations were applied to the T1 gray matter
segmented images and smoothed with an 8-mm full-width at
half-maximum isotropic Gaussian kernel.
SUIT Preprocessing (Cerebellum)
T1 images were additionally spatially normalized using the
spatially unbiased infratentorial template procedure (SUIT
version 2.7 [42]). SUIT normalization is known to have more
accurate inter-subject alignment of cerebellar structures; there-
fore, we used an isotropic Gaussian smoothing kernel of
4 mm. The SUIT procedure isolates the cerebellum and
brainstem and creates a mask. These masks were manually
corrected with the help of MRIcroN (http://www.
mccaus landcenter. sc .edu/mricro /mr icron) . Af te r
preprocessing, smoothed modulated normalized data with a
voxel size of 1 mm3 for DARTEL (181×217×181 voxels)
and SUIT (141×95×87 voxels) were obtained.
Obtaining Total Cerebellar Gray Matter Volumes
Masks were back-projected from SUIT space into native sub-
ject space using the inverted deformation from standard space
to subject space derived from the SUIT normalization proce-
dure. Total cerebellar gray matter volumes were subsequently
obtained with the get_totals Matlab function (http://www.cs.
ucl.ac.uk/staff/g.ridgway/vbm/get_totals.m).
Statistical Analysis
Voxel-wise comparisons of the local concentration of gray
matter between groups were performed by including
smoothed gray matter volumes into a general linear model.
All comparisons were corrected for age and total gray matter
volume, obtained from the VBM8 procedure described else-
where (http://dbm.neuro.uni-jena.de/vbm8/ [48]).
For study 1, two-sample t tests were performed to evaluate
local volumetric changes between (1) patients and controls,
(2) early onset (<40 years) versus late onset (≥40 years) tremor
Table 1 Clinical and demographic characteristics of subjects in studies
1 and 2
Study 1 Controls ET
Number 30 36
M/F 19/11 23/13
Age (years) 54±15 56±14
Disease duration (years) – 27±16
Head tremor (y/n) – 13/26
TRS A + B score off medication – 23±12
Propranolol dose (mg) – 72±64
Propranolol effect on TRS A + B – 3.34±3.8
Gray matter volume (ml) 575±62 573±74
Study 2 Controls ET FCMTE
Number 9 9 8
M/F 6/3 6/3 5/3
Age (years) 43±12 50±18 41±13
Disease duration (years) – 30.2±18 17±10
UMRS score – – 10±10
Gray matter volume 526±70 462±52 435±23
Mean±standard deviation. Propranolol effect is improvement determined
by difference between TRS A + B on and off propranolol medication
TRS Tremor Rating Scale
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patients, and (3) head tremor versus no head tremor patients.
Multiple regression analyses were performed in the patient
group, to correlate voxel-wise, local concentration of gray
matter with tremor severity (TRS part A and B), response to
propranolol (difference in TRS part A + B between on and off
medication), and disease duration.
For study 2, local graymatter volume of a separate group of
ET patients, FCMTE patients, and healthy controls was com-
pared using a general linear model, by a one-way ANCOVA
and post hoc two-sample t tests. All contrasts were obtained
for the cerebral cortex and cerebellar template. Cluster-wise
inference was used (P<0.05 (FWE corrected), cluster-forming
threshold P<0.001). The probabilistic atlas of the cerebellar
cortex and the Anatomy toolbox were used to determine ana-
tomical locations of volumetric differences [49, 50].
For study 3, group differences in total cerebellar volume
(TCV) were compared using a one-way ANCOVA, corrected
for age and T1 acquisition (study 1 T1 3D TFE image, study 2




Table 1 shows clinical and demographic data of the included
subjects. Of 36 ET patients included in study 1, 13 patients
had a head tremor. Mean disease duration did not differ be-
tween patients with or without head tremor (head tremor
25.9 years (SD 20.4 years) versus no head tremor 27.6 years
(12.9 years)).
Study 1—ET (Subgroups) Versus Controls
Whole brain and cerebellar VBM analyses did not reveal sig-
nificant differences between ET patients and controls. Within
ET patients, a subgroup comparison between ET patients with
and without head tremor showed a significant volume increase
in the bilateral precentral and postcentral gyrus and the left
superior medial gyrus in ET patients with head tremor (Figs. 1
and 2, Table 2). There was no relationship at whole brain or
cerebellar level between an increase and decrease of local gray
matter and tremor scores, disease duration, response to pro-
pranolol, or early versus late disease onset.
Study 2—Local Cerebellar Changes, FCMTE Versus ET
and Controls
In FCMTE patients compared to a separate group of ET pa-
tients and healthy controls, the SUIT analysis revealed wide-
spread gray matter loss throughout the cerebellum, mainly
confined to cerebellar motor areas, crus I, and lobules IX
and X (Fig. 3, Table 2). Whole brain ANCOVA analysis did
not reveal significant differences between ET patients,
FCMTE patients, and healthy controls.
Study 3—Total Cerebellar Volume, Differences
Between Pooled Groups
ET patients showed a mean TCV of 131 ml (SD 14 ml), for
FCMTE patients 105 ml (SD 23 ml), and for controls 130 ml
(SD 16 ml). There was a significant group effect for total
cerebellar volume (F(2)=6.8, P=0.002, corrected for age
and T1 acquisition protocol, Fig. 4). Post hoc independent t
tests revealed significantly decreased TCVin FCMTE patients
compared to controls (t[45]=3.66, P=0.001) and ET patients
(t[51]=4.4, P<0.001).
Fig. 1 Spiral drawings from an ET and FCMTE patient. Spirals drawn
with the right hand by an ET and an FCMTE patient
Fig. 2 Study 1—cortical volume increase in ET patients with head
tremor. Increased volume in ET patients with head tremor compared to
ET patients without head tremor. Increased volume is mainly confined to
the bilateral precentral gyrus and right superior medial gyrus. Cluster-
wise inference (P<0.05 (FWE corrected), cluster-forming threshold
P<0.001). Results are projected on the ch2better template in sagittal,
coronal, and axial views (MRIcroN, http://www.mccauslandcenter.sc.
edu/mricro/mricron)
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Discussion
In this report of a large sample of hereditary, propranolol-
sensitive ET patients with an age at onset before 65 years,
there was no decrease in local cortical or cerebellar graymatter
volume compared to age-matched healthy controls. In a sub-
group of ET patients with head tremor, we report a volume
increase in cortical regions (study 1). We report for the first
time global and localized cerebellar gray matter reduction in
FCMTE, compared to ET patients and healthy controls (study
2 and 3).
Study 1: No Decrease in Cerebellar or Cerebral Volume
in Essential Tremor
ET has been associated with Purkinje cell changes [26–29,
32–34, 51]. Our results indicate that the possible Purkinje cell
loss in hereditary ET does not give rise to macroscopic
Table 2 Local maxima of
increased volume in ET patients
with head tremor compared to ET
patients without head tremor and
local maxima of reduced volume
in FCMTE compared to ET and
controls
Region Hemisphere t Value PFWE-corr Cluster size x, y, z in mm
Study 1—ET head tremor > ET no head tremor
Postcentral gyrus Right 6.07 0.002 1396 59 −4 28
Precentral gyrus Right 5.16 44 17 34
Precentral gyrus Right 4.96 51 11 33
Superior medial gyrus Right 5.43 0.016 857 6 54 36
Superior medial gyrus Right 4.08 2 42 33
Superior medial gyrus Right 3.99 3 42 42
Postcentral gyrus Left 5.39 0.001 1414 −60 −3 28
Precentral gyrus Left 4.74 −50 6 39
Precentral gyrus Left 4.44 −48 11 31
Study 2—ET > FCMTE
Cerebellum crus II Left 5.37 0.005 1160 −25 −77 −42
Cerebellum lobule VI Left 4.75 −23 −62 −31
Cerebellum crus I Left 4.53 −34 −50 −35
Study 2—controls > FCMTE
Cerebellum lobule VIIIa Right 6.11 <0.001 4522 12 −67 −42
Cerebellum crus I Right 5.41 25 −74 −34
Cerebellum lobule V Right 5.33 14 −51 −18
Cerebellum crus I Left 5.45 <0.001 3188 −20 −74 −33
Cerebellum lobule VI Left 4.91 −18 −64 −27
Cerebellum crus I Left 4.70 −37 −49 −36
Cerebellum lobule IX Left 5.30 <0.001 3133 −14 −46 −48
Cerebellum lobule VIIIb Left 4.97 −16 −60 −47
Cerebellum lobule X Left 4.59 −21 −43 −45
Cerebellum lobule IX Right 5.27 0.01 990 8 −55 −52
Cerebellum lobule VIIIb Right 4.92 5 −62 −39
Cerebellum lobule IX Right 4.47 6 −49 −43
Stereotactic coordinates of the local maxima of clusters showing volume reduction in FCMTE compared to ET
and controls (cluster-wise inference was used (P<0.05 (FWE corrected), cluster-forming threshold P<0.001).
Cluster size is given in number of voxels. MNI stereotactic coordinates for cortical regions, SUIT coordinates for
infratentorial regions
Fig. 3 Study 2—cerebellar volume reduction in FCMTE. Cerebellar
VBM results show volume reduction in FCMTE compared to healthy
controls and ET patients. Cluster-wise inference (P<0.05 (FWE
corrected), cluster-forming threshold P<0.001). Results are projected
on the SUIT atlas [42]
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atrophy. A previous study byDaniels and colleagues could not
objectify cerebellar atrophy in ETcompared to controls either;
however, the presence of more subtle changes in the cerebellar
gray matter could not be excluded [19]. We have focused our
analysis on the cerebellum using the SUIT toolbox. The SUIT
toolbox provides two advantages compared to the standard
analysis. Normalization using the SUIT approach improves
the overlap of cerebellar structures between subjects, and by
masking the image before reslicing it into atlas space, no
supra-tentorial gray matter can bias the results [42]. This al-
lows to state with more certainty that volumetric differences
are within the range of age-related atrophy, at least in heredi-
tary ET.
Cortical volumetric changes in ET found in previous stud-
ies are not consistent (Supplementary Table 1). The large dis-
crepancies between results of structural imaging studies in
essential tremor may be explained by disease heterogeneity,
different inclusion criteria and different definitions of ET sub-
groups between studies and/or methodological differences in-
cluding differences in magnetic field strength, and use of more
liberal statistical thresholds. In fact, results due to methodo-
logical or biological differences can appear very similar using
volumetric analyses [52]. This makes the interpretation and
generalizability of these results challenging. In our analysis,
we have chosen for a validated approach with a statistical
threshold corrected for multiple comparisons. Based on our
results of no volumetric differences related to hereditary ET,
combined with previous findings, we postulate that macro-
scopic volumetric changes are not a characteristic of heredi-
tary ET, at least not perceptible with a smoothing kernel of
4 mm [19].
As mentioned in the Introduction, there are three mu-
tual ly non-exclus ive hypotheses regarding the
pathophysiology of ET. The first being that of an
Boscillating network disorder,^ the second hypothesis
regards ET as a neurodegenerative disorder, with evi-
dence for Purkinje cell loss and axonal swelling
[26–31]. Finally, ET is associated with abnormal func-
tioning of the inhibitory neurotransmitter GABA. With
respect to the neurodegenerative hypothesis, one could
hypothesize that Purkinje cell loss should give rise to
macroscopic cerebellar atrophy, as is observed in
FCMTE patients [33, 34, 53]. However, most pathology
studies in ET emphasize al tered Purkinje cel l
morphometry instead of large decrease in Purkinje cell
count [54], as opposed to the more extended Purkinje
cell loss in FCMTE [33, 34, 53]. GABAergic neuro-
transmission dysfunction within the cerebellum has been
reported in ET, with increased 11C-flunazenil binding to
GABA receptors in the cerebellar cortex, increasing
with tremor severity, and in the dentate nucleus, sug-
gesting functional cerebellar changes [55, 56]. Addition-
ally, a decrease in GABA receptors has been observed
in the dentate nucleus in ET [57]. Our findings do not
refute either hypothesis but are, because of lack of local
atrophy, to our opinion consistent with functional cere-
bellar changes in ET.
Volumetric Changes Related to Head Tremor
We did observe increased volume in cortical regions related to
motor control in ET patients with head tremor compared to ET
patients without head tremor. This increase in volume might
be explained in multiple ways. The most plausible hypothesis
is that the volumetric increase of cortical motor regions indi-
cates that cortical plasticity occurs in response to continuous
involuntary head movements. If this was to be true, one could
speculate that a volume increase of the motor cortex in general
would be associated with ET, since the hands are well-
represented in the human motor cortex. One assumption could
be that limb tremor is possibly less omnipresent throughout
the day compared to head tremor and therefore does not give a
volume increase of the associated hand areas. Alternative ex-
planations might be that these areas are primarily affected in
the ET subtype exhibiting head tremor or that these patients
are more prone to develop head tremor to start with. In this
light, it would be of interest to compare ET patients with head
tremor with patients with cervical dystonia, to observe wheth-
er similar plastic changes occur. Gray matter volume increase
in the primary motor cortex has been observed previously in
patients with dystonia and even more clearly in patients with
cervical dystonia [58].
Two previous studies, from the same group, reported cere-
bellar vermal gray matter reduction in ET patients with head
tremor [5, 59]. We were unable to confirm these results, even
in a post hoc analysis with a statistical threshold of P=0.001,
Fig. 4 Study 3—total cerebellar volume. Total cerebellar volume of
combined subjects from studies 1 and 2. Dot plots of total cerebellar
volume for ET patients, FCMTE patients, and controls, respectively. P
values based on two-sided t tests
Cerebellum (2016) 15:696–704 701
uncorrected for multiple comparisons, to further increase the
specificity of our findings. In previous studies, the head tremor
group was significantly older, with a mean age difference of
10 years with ET patients without head tremor [5]. In our
study, mean age did not differ between ET patients with and
without head tremor. Our study was not specifically powered
to assess gray matter reduction related to head tremor in ET.
Therefore, another explanation could be an insufficient sam-
ple size of subgroups (13 patients in the current study versus
19 and 20 patients with head tremor in the previous studies)
[5, 59].
Study 2 and 3: Cerebellar Atrophy in FCMTE
This is the first report of widespread regional cerebellar
atrophy in FCMTE compared to ET and healthy controls.
Previously, pathology studies revealed global cerebral and
cerebellar atrophy in FCMTE [33, 34]. Widespread volu-
metric changes throughout the cerebellum could be caused
by the evident Purkinje cell loss, observed in FCMTE
[32–34, 39]. Cerebellar fiber density does appear to be
decreased in FCMTE compared to ET and healthy controls
[39]. In this same study, no decrease in cerebellar volume
was observed in FCMTE. However, in this study, the au-
thors used a less sensitive technique by annotating the cer-
ebellum based on the fractional anisotropy and mean diffu-
sivity volumes, with a lower spatial resolution [39]. Func-
tional MRI and (1)H-MR spectroscopy studies have provid-
ed evidence for a crucial role of the cerebellum in the
pathophysiology of FCMTE [45, 60] that were confirmed
with PA studies showing almost isolated Purkinje cell
changes [33, 34]. In FCMTE, tremulous movements are
believed to originate from the sensorimotor cortex, in fact
being cortical myoclonus. Cerebellar pathological changes,
reflected in our finding of marked cerebellar atrophy, can
lead to decreased cerebellar inhibition of the dentato-
thalamic-cortical tracts [33, 34, 61, 62]. It is hypothesized
that reduced inhibitory Purkinje cell output onto the dentate
nucleus causes this decreased inhibition [61, 62].
In conclusion, based on the current study, atrophy seems
not to be a characteristic of hereditary ET. Considering that
our study has failed to find local volumetric changes in a
selected group of hereditary ET patients indicates that even
if these changes were to be present, they would be smaller
than age-related differences. We furthermore have shown a
volumetric increase of cortical motor areas related to head
tremor. Moreover, in a clear Purkinjopathy, such as FCMTE,
widespread cerebellar volumetric changes were objectified.
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